Media

Support Of Industry Underscores Pro-Business Commitment
Commercialization of cleaner, safer consumer products through innovative industrial biotechnology processes will be the focus of breakout sessions at the...

Press Releases

Feb 28 2002
Washington, D.C. (February 28, 2002)-The board of directors of the Biotechnology Industry Organization (BIO) voted unanimously to add Susan Desmond-Hellmann, M...
Feb 28 2002
Washington, D.C. (February 28, 2002)-The Biotechnology Industry Organization (BIO) board of directors has by unanimous vote named Dennis M. Fenton, Ph.D., to...
Feb 27 2002
Washington, D.C. (February 27, 2002)-Two heroes, one from Canada and one from the U.S. were named today as headlining speakers for the BIO 2002 International...
Feb 22 2002
WHERE: Waldorf=Astoria Hotel, New York 10:40 a.m. – 12: 00 p.m.Investor Session 13Jade Room Enhancing the Therapeutic Profile of Anti-cancer Compounds...
Feb 21 2002
Where: Waldorf=Astoria Hotel, New York 9:30 - 10:30 a.m.Press ConferenceHerbert Hoover Room Accenture Press Conference - Accenture will hold a press conference...
Feb 21 2002
New York– (February 21, 2002) – CV Therapeutics and Isis Pharmaceuticals were presented with the seventh Annual Helix Award at the Biotechnology...
Feb 21 2002
(Dr. Michael J. Phillips, executive director for food and agriculture of the Biotechnology Industry Organization (BIO) issued the following statement in...
Feb 20 2002
8:00 - 9:20 a.m.Opening PlenaryGrand Ballroom2001: A Record Year in Biotech M & A - This panel will feature executives from Vertex Pharmaceuticals, Aviron...
Feb 20 2002
New York (February 20, 2002)-Judges, lawyers and scientists are challenged with complex and novel legal issues surrounding cutting-edge biotechnology research...